Newsroom | 22494 results
Sorted by: Latest
-
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz, Bio-Rad’s co-founder and Director Emeritus, passed away on September 25, 2025, at the age of 99. Mrs. Schwartz co-founded Bio-Rad in 1952 in Berkeley, California, together with her husband David Schwartz, shortly after graduating with a biochemistry degree from the University of California, Berkel...
-
VISIUM Announces Installation of Visium Devices at Miami Dolphins Training Facility in Clean Air Advancement
ORLANDO, Fla.--(BUSINESS WIRE)--VISIUM today announced the installation of its Visium Far-UVC sanitization technology at the Miami Dolphins training facility, the Baptist Health Training Complex, ushering in a new era of protection to further improve athlete health and performance. This partnership demonstrates VISIUM’s innovative application in professional sports, offering an added layer of biosecurity to support player health, recovery, and availability. Visium technology uses a specific wav...
-
Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced positive topline data from RSVHR, a Phase 2b, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of zelicapavir in outpatient adults with acute RSV infection who are at high risk of complications including the elderly and/or those with...
-
Riassunto: Giornata internazionale delle persone anziane: AOP Health mette sotto i riflettori il peso silenzioso delle ulcere venose degli arti inferiori
VIENNA--(BUSINESS WIRE)--In occasione della Giornata internazionale delle persone anziane indetta dalle Nazioni Unite, AOP Health richiama l’attenzione sull’impatto spesso invisibile che le ulcere venose croniche hanno sulle persone anziane. Si tratta di ferite dolorose e a lenta guarigione che si manifestano agli arti inferiori e possono privare le persone di mobilità, indipendenza e dignità. Data la gravità delle conseguenze, è essenziale riconoscere tempestivamente i sintomi e rivolgersi a u...
-
Journée internationale pour les personnes âgées : AOP Health met en lumière le fardeau silencieux des ulcères veineux des jambes
VIENNE--(BUSINESS WIRE)--À l’occasion de la Journée internationale pour les personnes âgées créée par les Nations unies, AOP Health attire l’attention sur l’impact souvent invisible des ulcères veineux chroniques (UVC) chez les personnes âgées. Les UVC sont des plaies douloureuses et lentes à cicatriser qui apparaissent sur les membres inférieurs et peuvent priver les personnes de leur mobilité, de leur indépendance et de leur dignité. Compte tenu de leurs graves conséquences, il est essentiel...
-
Resumen: Día internacional de las personas mayores: AOP Health saca a la luz el problema invisible de las úlceras venosas en las piernas
VIENA--(BUSINESS WIRE)--En el Día internacional de las personas mayores de las Naciones Unidas, AOP Health llama la atención sobre el impacto, a menudo invisible, que las úlceras venosas crónicas (UVC) tienen en las personas mayores. Las UVC son heridas dolorosas y de curación lenta que se producen en las extremidades inferiores y pueden privar a las personas de movilidad, independencia y dignidad. Dadas las graves consecuencias, es fundamental estar atento a los primeros síntomas y consultar a...
-
International Day of Older Persons: AOP Health Shines a Light on the Silent Burden of Venous Leg Ulcers
VIENNA--(BUSINESS WIRE)--On the United Nations’ International Day of Older Persons, AOP Health draws attention to the often-invisible impact that Chronic Venous Ulcer (CVU) wounds have on older people. CVU are painful, slow-healing wounds that occur on the lower limb and can deprive people of mobility, independence, and dignity. Given the serious consequences, it’s vital to watch for early symptoms and speak to a doctor. Coordinated, multidisciplinary care can support recovery and independence...
-
Samenvatting: Internationale Dag van de Ouderen: AOP Health vestigt de aandacht op de stille last van veneuze beenulcera
WENEN--(BUSINESS WIRE)--Op de Internationale Dag van de Ouderen van de Verenigde Naties vestigt AOP Health de aandacht op de vaak onzichtbare impact die chronische veneuze ulcera (CVU's) hebben op ouderen. CVU's zijn pijnlijke, langzaam genezende wonden die voorkomen aan de onderste ledematen en die mensen hun mobiliteit, onafhankelijkheid en waardigheid kunnen ontnemen. Gezien de ernstige gevolgen is het van cruciaal belang om op vroege symptomen te letten en een arts te raadplegen. Gecoördine...
-
Internationaler Tag der älteren Menschen: AOP Health klärt über die oft unterschätzte Gefahr von venösen Beingeschwüren auf
WIEN--(BUSINESS WIRE)--Anlässlich des von den Vereinten Nationen ausgerufenen Internationalen Tages der älteren Menschen lenkt AOP Health die Aufmerksamkeit auf die oft nicht wahrgenommenen Folgen, die Wunden aufgrund chronischer venöser Ulzera (CVU) für ältere Menschen haben. Bei CVU handelt es sich um schmerzhafte, langsam heilende Wunden an den unteren Extremitäten, durch die Betroffene in ihrer Mobilität und Unabhängigkeit eingeschränkt werden und die ihnen das Gefühl vermitteln können, ihr...
-
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their prescribed medications at a transparent cash price with home delivery. AstraZeneca Direct will support people living with chronic conditions such as asthma, diabetes, heart failure and chronic kidney disease, and people seeking flu protection. Starting October 1, 2025, eligible patients with prescrip...